Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-06
DOI
10.3389/fimmu.2022.888392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
- (2022) Celine Kaegi et al. Frontiers in Immunology
- Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases
- (2021) Giulio Cavalli et al. AUTOIMMUNITY REVIEWS
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
- (2020) Alice Gottlieb et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
- (2020) Claudia Kedor et al. ANNALS OF THE RHEUMATIC DISEASES
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- (2020) Lars Fugger et al. CELL
- Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
- (2020) Celine Kaegi et al. Frontiers in Immunology
- Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
- (2020) Seza Ozen et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic review of safety and efficacy of belimumab in treating immune‐mediated disorders
- (2020) Celine Kaegi et al. ALLERGY
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
- (2020) Allan L. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Basis of IL-1 Family Cytokine Signaling
- (2019) James K. Fields et al. Frontiers in Immunology
- Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
- (2019) Celine Kaegi et al. Frontiers in Immunology
- Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades
- (2018) Vesa Eskola et al. ACTA PAEDIATRICA
- MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
- (2018) Theodora Kanni et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
- (2018) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Gevokizumab in Patients with Behçet’s Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study
- (2018) Ilknur Tugal-Tutkun et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- A phase I study of anti-inflammatory therapy with rilonacept in adolescents and adults with type 1 diabetes mellitus
- (2018) Perrin C White et al. PEDIATRIC DIABETES
- Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
- (2018) Carly A Janssen et al. RHEUMATOLOGY
- Successful Treatment of Autoimmune Disease–Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra
- (2017) Celia Beynon et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study
- (2017) Karoline Krause et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study
- (2017) C. Bottin et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Ilan Ben-Zvi et al. Arthritis & Rheumatology
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Interleukin-1 antagonism in type 1 diabetes of long duration
- (2016) E. Seelig et al. DIABETES & METABOLISM
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
- (2016) Torbjörn Kullenberg et al. RHEUMATOLOGY
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- Canakinumab in adults with steroid-refractory pyoderma gangrenosum
- (2015) A.G.A. Kolios et al. BRITISH JOURNAL OF DERMATOLOGY
- An overview of FDA-approved biologics medicines
- (2015) Michael S. Kinch DRUG DISCOVERY TODAY
- Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
- (2014) Antonio Vitale et al. DERMATOLOGY
- Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
- (2014) J. S. Sundy et al. JOURNAL OF RHEUMATOLOGY
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever
- (2013) Philip J. Hashkes et al. ANNALS OF INTERNAL MEDICINE
- Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
- (2013) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study
- (2013) Karoline Krause et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
- (2013) Essack Mitha et al. RHEUMATOLOGY
- Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
- (2013) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
- (2013) Robert A Terkeltaub et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
- (2012) K. Krause et al. ALLERGY
- IL-1 Trap rilonacept in refractory adult onset Still's disease
- (2012) Olga Petryna et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra treatment of SAPHO syndrome: short-term results of an open study
- (2012) Daniel Wendling et al. ANNALS OF THE RHEUMATIC DISEASES
- Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
- (2012) H. Ralph Schumacher et al. ARTHRITIS AND RHEUMATISM
- Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes
- (2012) Cailin H. Sibley et al. ARTHRITIS AND RHEUMATISM
- Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
- (2012) D. NORDSTROM et al. JOURNAL OF RHEUMATOLOGY
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
- (2012) Katrine Brække Norheim et al. PLoS One
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Secondary failure to treatment with recombinant human IL-1 receptor antagonist in Chinese patients with rheumatoid arthritis
- (2011) Jun Bao et al. CLINICAL RHEUMATOLOGY
- XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases
- (2011) Alexander M. Owyang et al. mAbs
- Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis
- (2011) Xiaoyin Niu et al. MOLECULAR IMMUNOLOGY
- Genetics of monogenic autoinflammatory diseases: past successes, future challenges
- (2011) Ivona Aksentijevich et al. Nature Reviews Rheumatology
- Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
- (2011) Isabelle Koné-Paut et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- (2010) Alexander So et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome
- (2010) Jasmin B. Kuemmerle-Deschner et al. ARTHRITIS AND RHEUMATISM
- An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)
- (2010) Norma Jung et al. CLINICAL RHEUMATOLOGY
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra
- (2010) Loredana Lepore et al. JOURNAL OF PEDIATRICS
- Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature
- (2010) JT Gran et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome
- (2008) M. Gattorno et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
- (2008) Norman Ilowite et al. CLINICAL RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started